Genprex
Quarterly Financials
| Values in thousands | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|
Revenue | $0 | $9 | $0 | $0 |
Gross Profit | -1 | |||
EBITDA | -4,681 | -3,967 | -4,322 | |
EBIT | -4,681 | -3,969 | -4,335 | -4,323 |
Net Income | -4,674 | -3,964 | -4,330 | -4,315 |
Net Change In Cash | 0 | 9 | 0 | 0 |
Free Cash Flow | -3,864 | -4,161 | -3,869 | -2,168 |
Cash | 1,346 | 3,468 | 1,601 | 1,488 |
Basic Shares | 27,593 | 15,265 | 10,860 | 3,499 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -6 | -15 | -23,830 | -22 |
EBITDA | -21,104 | -31,060 | -23,805 | -20,647 |
EBIT | -21,111 | -31,075 | -23,830 | -20,670 |
Net Income | -21,388,282 | -30,860 | -23,740 | -20,664 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -17,149 | -24,809 | -17,838 | -14,368 |
Cash | 1,601 | 6,737 | 20,954 | 38,628 |
Basic Shares | 4,005 | 1,367 | 1,198 | 1,177 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-06-30 | -$0.17 |
2025-03-31 | -$0.26 |
2024-12-31 | -$0.42 |
2024-09-30 | -$1.23 |
